Cargando…
Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients
The role of cell-mediated immunity in human SARS-CoV infection is still not well understood. In this study, we found that memory T-cell responses against the spike (S) protein were persistent for more than 1 year after SARS-CoV infection by detecting the production of IFN-γ using ELISA and ELISpot a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106132/ https://www.ncbi.nlm.nih.gov/pubmed/16781892 http://dx.doi.org/10.1016/j.clim.2006.05.002 |
_version_ | 1783512555205951488 |
---|---|
author | Yang, Li-Tao Peng, Hui Zhu, Zhao-Ling Li, Gang Huang, Zi-Tong Zhao, Zhi-Xin Koup, Richard A. Bailer, Robert T. Wu, Chang-You |
author_facet | Yang, Li-Tao Peng, Hui Zhu, Zhao-Ling Li, Gang Huang, Zi-Tong Zhao, Zhi-Xin Koup, Richard A. Bailer, Robert T. Wu, Chang-You |
author_sort | Yang, Li-Tao |
collection | PubMed |
description | The role of cell-mediated immunity in human SARS-CoV infection is still not well understood. In this study, we found that memory T-cell responses against the spike (S) protein were persistent for more than 1 year after SARS-CoV infection by detecting the production of IFN-γ using ELISA and ELISpot assays. Flow cytometric analysis showed that both CD4(+) and CD8(+) T cells were involved in cellular responses against SARS-CoV infection. Interestingly, most of SARS-CoV S-specific memory CD4(+) T cells were central memory cells expressing CD45RO(+) CCR7(+) CD62L(−). However, the majority of memory CD8(+) T cells revealed effector memory phenotype expressing CD45RO(−) CCR7(−) CD62L(−). Thus, our study provides the evidence that SARS-CoV infection in humans can induce cellular immune response that is persistent for a long period of time. These data may have an important implication in the possibility of designing effective vaccine against SARS-CoV infection, specifically in defining T-cell populations that are implicated in protective immunity. |
format | Online Article Text |
id | pubmed-7106132 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71061322020-03-31 Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients Yang, Li-Tao Peng, Hui Zhu, Zhao-Ling Li, Gang Huang, Zi-Tong Zhao, Zhi-Xin Koup, Richard A. Bailer, Robert T. Wu, Chang-You Clin Immunol Article The role of cell-mediated immunity in human SARS-CoV infection is still not well understood. In this study, we found that memory T-cell responses against the spike (S) protein were persistent for more than 1 year after SARS-CoV infection by detecting the production of IFN-γ using ELISA and ELISpot assays. Flow cytometric analysis showed that both CD4(+) and CD8(+) T cells were involved in cellular responses against SARS-CoV infection. Interestingly, most of SARS-CoV S-specific memory CD4(+) T cells were central memory cells expressing CD45RO(+) CCR7(+) CD62L(−). However, the majority of memory CD8(+) T cells revealed effector memory phenotype expressing CD45RO(−) CCR7(−) CD62L(−). Thus, our study provides the evidence that SARS-CoV infection in humans can induce cellular immune response that is persistent for a long period of time. These data may have an important implication in the possibility of designing effective vaccine against SARS-CoV infection, specifically in defining T-cell populations that are implicated in protective immunity. Elsevier Inc. 2006-08 2006-06-16 /pmc/articles/PMC7106132/ /pubmed/16781892 http://dx.doi.org/10.1016/j.clim.2006.05.002 Text en Copyright © 2006 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Yang, Li-Tao Peng, Hui Zhu, Zhao-Ling Li, Gang Huang, Zi-Tong Zhao, Zhi-Xin Koup, Richard A. Bailer, Robert T. Wu, Chang-You Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients |
title | Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients |
title_full | Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients |
title_fullStr | Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients |
title_full_unstemmed | Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients |
title_short | Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients |
title_sort | long-lived effector/central memory t-cell responses to severe acute respiratory syndrome coronavirus (sars-cov) s antigen in recovered sars patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106132/ https://www.ncbi.nlm.nih.gov/pubmed/16781892 http://dx.doi.org/10.1016/j.clim.2006.05.002 |
work_keys_str_mv | AT yanglitao longlivedeffectorcentralmemorytcellresponsestosevereacuterespiratorysyndromecoronavirussarscovsantigeninrecoveredsarspatients AT penghui longlivedeffectorcentralmemorytcellresponsestosevereacuterespiratorysyndromecoronavirussarscovsantigeninrecoveredsarspatients AT zhuzhaoling longlivedeffectorcentralmemorytcellresponsestosevereacuterespiratorysyndromecoronavirussarscovsantigeninrecoveredsarspatients AT ligang longlivedeffectorcentralmemorytcellresponsestosevereacuterespiratorysyndromecoronavirussarscovsantigeninrecoveredsarspatients AT huangzitong longlivedeffectorcentralmemorytcellresponsestosevereacuterespiratorysyndromecoronavirussarscovsantigeninrecoveredsarspatients AT zhaozhixin longlivedeffectorcentralmemorytcellresponsestosevereacuterespiratorysyndromecoronavirussarscovsantigeninrecoveredsarspatients AT koupricharda longlivedeffectorcentralmemorytcellresponsestosevereacuterespiratorysyndromecoronavirussarscovsantigeninrecoveredsarspatients AT bailerrobertt longlivedeffectorcentralmemorytcellresponsestosevereacuterespiratorysyndromecoronavirussarscovsantigeninrecoveredsarspatients AT wuchangyou longlivedeffectorcentralmemorytcellresponsestosevereacuterespiratorysyndromecoronavirussarscovsantigeninrecoveredsarspatients |